WeVote

Bill

Bill

SB 458

AN ACT AUTHORIZING THE OFFICE OF THE ATTORNEY GENERAL TO INVESTIGATE AND INITIATE LEGAL PROCEEDINGS IN RESPONSE TO ALLEGED PRICE GOUGING BY THE INSURANCE, PHARMACEUTICAL, PHARMACY BENEFIT MANAGEMENT AND UTILITY SECTORS.

2025 Regular Session Introduced by Saud Anwar

Connecticut empowers its Attorney General to investigate and sue businesses in insurance, pharma, PBMs, and utilities for alleged price gouging without defining clear pricing standards.

REF. TO JOINT COMM. ON Judiciary
0
WeVote Research Nonpartisan
Bill Summary · SB 458

Legislative bill overview

SB 458 grants Connecticut's Attorney General expanded authority to investigate and pursue legal action against alleged price gouging in four specific sectors: insurance, pharmaceuticals, pharmacy benefit managers (PBMs), and utilities. The bill creates a framework for the state to take enforcement action when businesses in these industries are suspected of engaging in unfair pricing practices.

Why is this important

Price gouging investigations directly affect consumers' access to essential services and medications. By empowering the Attorney General, Connecticut would join other states in actively policing sudden or unjustified price spikes, potentially reducing healthcare and utility costs for residents. However, the definition and enforcement of "price gouging" remains contentious, as legitimate price increases can be difficult to distinguish from exploitative ones.

Potential points of contention

  • Definition clarity: The bill doesn't specify what constitutes "price gouging" in these sectors, leaving significant discretion to the Attorney General and potentially creating uncertainty for businesses about legal compliance
  • Industry pushback: Insurance companies, pharmaceutical makers, and utilities may argue the provision interferes with market competition and pricing flexibility needed to fund operations and innovation
  • PBM oversight complexity: PBMs operate in a complicated supply chain; determining whether pricing is exploitative requires understanding rebates, middleman negotiations, and cost structures that are often opaque

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.